Rudick RA - Search Results

1

Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS.

Rudick RA, Cutter G, Baier M, Fisher E, Dougherty D, Weinstock-Guttman B, Mass MK, Miller D, Simonian NA. Rudick RA, et al. Neurology. 2001 May 22;56(10):1324-30. doi: 10.1212/wnl.56.10.1324. Neurology. 2001. PMID: 11376182

2

Low-dose (7.5 mg) oral methotrexate for chronic progressive multiple sclerosis. Design of a randomized, placebo-controlled trial with sample size benefits from a composite outcome variable including preliminary data on toxicity.

Goodkin DE, Rudick RA, VanderBrug Medendorp S, Greene T, Schwetz KM, Fischer J, Daughtry MM, Ross J, Van Dyke C. Goodkin DE, et al. Among authors: rudick ra. Online J Curr Clin Trials. 1992 Sep 25;Doc No 19:[7723 words; 89 paragraphs]. Online J Curr Clin Trials. 1992. PMID: 1343611 Clinical Trial.

3

Experimental therapies for multiple sclerosis: current status.

Goodkin DE, Ransohoff RM, Rudick RA. Goodkin DE, et al. Among authors: rudick ra. Cleve Clin J Med. 1992 Jan-Feb;59(1):63-74. doi: 10.3949/ccjm.59.1.63. Cleve Clin J Med. 1992. PMID: 1372538 Free article. Review.

4

Quality of life in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritis.

Rudick RA, Miller D, Clough JD, Gragg LA, Farmer RG. Rudick RA, et al. Arch Neurol. 1992 Dec;49(12):1237-42. doi: 10.1001/archneur.1992.00530360035014. Arch Neurol. 1992. PMID: 1449401

5

Volume T1-weighted gradient echo MRI in multiple sclerosis patients.

Shah M, Ross JS, VanDyke C, Rudick RA, Goodkin DE, Obuchowski N, Modic MT. Shah M, et al. Among authors: rudick ra. J Comput Assist Tomogr. 1992 Sep-Oct;16(5):731-6. doi: 10.1097/00004728-199209000-00012. J Comput Assist Tomogr. 1992. PMID: 1522265

6

Magnetic resonance imaging lesion enlargement in multiple sclerosis. Disease-related activity, chance occurrence, or measurement artifact?

Goodkin DE, Ross JS, Medendorp SV, Konecsni J, Rudick RA. Goodkin DE, et al. Among authors: rudick ra. Arch Neurol. 1992 Mar;49(3):261-3. doi: 10.1001/archneur.1992.00530270075021. Arch Neurol. 1992. PMID: 1536628

7

Cytokine secretion by multiple sclerosis monocytes. Relationship to disease activity.

Rudick RA, Ransohoff RM. Rudick RA, et al. Arch Neurol. 1992 Mar;49(3):265-70. doi: 10.1001/archneur.1992.00530270079022. Arch Neurol. 1992. PMID: 1536629

8

Diagnostic criteria for multiple sclerosis research involving multiply affected families.

Goodkin DE, Doolittle TH, Hauser SS, Ransohoff RM, Roses AD, Rudick RA. Goodkin DE, et al. Among authors: rudick ra. Arch Neurol. 1991 Aug;48(8):805-7. doi: 10.1001/archneur.1991.00530200041016. Arch Neurol. 1991. PMID: 1898254

9

Stereotactic biopsy of an active multiple sclerosis lesion. Immunocytochemical analysis and neuropathologic correlation with magnetic resonance imaging.

Estes ML, Rudick RA, Barnett GH, Ransohoff RM. Estes ML, et al. Among authors: rudick ra. Arch Neurol. 1990 Dec;47(12):1299-303. doi: 10.1001/archneur.1990.00530120043008. Arch Neurol. 1990. PMID: 1979221

10

Relative diagnostic value of cerebrospinal fluid kappa chains in MS: comparison with other immunoglobulin tests.

Rudick RA, French CA, Breton D, Williams GW. Rudick RA, et al. Neurology. 1989 Jul;39(7):964-8. doi: 10.1212/wnl.39.7.964. Neurology. 1989. PMID: 2500621

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

266 results

Search Page

Filters